Parameter
| Biomarker | WT1 | Full name | Wilms Tumor 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, prognosis, and treatment response monitoring | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow/blood (RNA sequencing, qPCR) | ||
| Pathobiological Mechanisms | Overexpression is associated with elevated white blood cell count and increased proportion of primitive cells, with expression levels decreasing after induction therapy. | ||||
| Clinical Availability Status | Clinical validation: 345 diagnostic samples confirm its value. | ||||
| Notes and Dynamics | Can monitor disease status and guide risk stratification and treatment decisions. | ||||